Huron Consulting Group Inc. (NASDAQ:HURN) Shares Sold by Jennison Associates LLC

Jennison Associates LLC reduced its stake in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 17.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 495,328 shares of the business services provider's stock after selling 106,007 shares during the quarter. Jennison Associates LLC owned approximately 2.76% of Huron Consulting Group worth $71,055,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Franklin Resources Inc. raised its stake in Huron Consulting Group by 16.4% in the fourth quarter. Franklin Resources Inc. now owns 460,650 shares of the business services provider's stock valued at $57,240,000 after buying an additional 64,862 shares during the last quarter. Norges Bank purchased a new stake in Huron Consulting Group in the fourth quarter valued at about $7,427,000. Sunriver Management LLC raised its stake in Huron Consulting Group by 10.7% in the fourth quarter. Sunriver Management LLC now owns 486,597 shares of the business services provider's stock valued at $60,465,000 after buying an additional 46,968 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Huron Consulting Group by 27.4% in the first quarter. Assenagon Asset Management S.A. now owns 177,449 shares of the business services provider's stock valued at $25,455,000 after buying an additional 38,163 shares during the last quarter. Finally, Millennium Management LLC raised its stake in Huron Consulting Group by 58.7% in the fourth quarter. Millennium Management LLC now owns 92,872 shares of the business services provider's stock valued at $11,540,000 after buying an additional 34,353 shares during the last quarter. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Huron Consulting Group news, Director Joy Brown sold 668 shares of the business's stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $149.74, for a total transaction of $100,026.32. Following the transaction, the director owned 8,896 shares of the company's stock, valued at approximately $1,332,087.04. The trade was a 6.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John Mccartney sold 500 shares of the business's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $136.74, for a total value of $68,370.00. Following the transaction, the director directly owned 51,817 shares in the company, valued at $7,085,456.58. This trade represents a 0.96% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,708 shares of company stock valued at $377,421. Insiders own 2.15% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on HURN shares. Barrington Research increased their price target on Huron Consulting Group from $167.00 to $173.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Benchmark restated a "buy" rating and issued a $165.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, March 26th. William Blair restated an "outperform" rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Wedbush raised their price objective on Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 26th. Finally, Wall Street Zen cut Huron Consulting Group from a "buy" rating to a "hold" rating in a research note on Friday, May 2nd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $170.75.

Huron Consulting Group Stock Performance

Huron Consulting Group stock traded up $0.89 during midday trading on Tuesday, hitting $131.11. 123,109 shares of the company were exchanged, compared to its average volume of 156,146. The firm has a market capitalization of $2.26 billion, a PE ratio of 19.66 and a beta of 0.28. Huron Consulting Group Inc. has a fifty-two week low of $101.73 and a fifty-two week high of $155.00. The business has a fifty day simple moving average of $139.44 and a two-hundred day simple moving average of $138.02. The company has a debt-to-equity ratio of 1.14, a quick ratio of 2.08 and a current ratio of 2.08.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating the consensus estimate of $1.16 by $0.52. The company had revenue of $404.14 million for the quarter, compared to analyst estimates of $389.27 million. Huron Consulting Group had a return on equity of 24.68% and a net margin of 7.88%. Huron Consulting Group's quarterly revenue was up 11.2% compared to the same quarter last year. During the same period last year, the company earned $1.23 earnings per share. On average, sell-side analysts forecast that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.